Colombian experience in the management of hepatitis C
Ver / Descargar
Fecha
2020-06-29Autor(es) Corporativo(s)
Pontificia Universidad Javeriana. Facultad de Medicina. Departamento de Epidemiología Clínica y Bioestadística
Tipo
Artículo de revista
ISSN
1478-3223 / 1478-3231 (Electrónico)
COAR
Carta al editorCompartir este registro
Citación
Documentos PDF
Abstract
In a past issue of the journal, Schroeder et al.1
discuss the experience and prospects of hepatitis C in
different countries; Colombia, however, was left out. Our country has had an agreement with the
Pan American Health Organization (PAHO) since 2010 to participate in a regional fund for the
acquisition of strategic public health products. Hepatitis C medications were being bought at high
prices, with generic medicines at the same level as original products. Health insurers would
independently purchase their medications at high market prices, expecting reimbursement from the
government.
Enlace al recurso
https://onlinelibrary.wiley.com/doi/epdf/10.1111/liv.14582Fuente
Liver international; Volumen 40 Número 12 , Página 3143 (2020)
Estadísticas Google Analytics
Colecciones
- Artículos [682]